Activation of 5-HT2 Receptors Reduces Inflammation in Vascular Tissue and Cholesterol Levels in High-Fat Diet-Fed Apolipoprotein E Knockout Mice

Management of Statin Intolerance in 2018: Still More Questions Than Answers

(2018) Peter P. Toth et al.   American Journal of Cardiovascular Drugs

Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming

(2018) Anette Christ et al.   CELL

Cardiovascular safety of lorcaserin

(2018) Gregory B. Lim   Nature Reviews Cardiology

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

(2017) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

Psychedelic Drugs in Biomedicine

(2017) Evan J. Kyzar et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

(2017) Gregg C. Fonarow et al.   JAMA Cardiology

Psychedelics as Medicines: An Emerging New Paradigm

(2016) DE Nichols et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effect of a human serotonin 5-HT2A receptor gene polymorphism on impulsivity: Dependence on cholesterol levels

(2016) Katrin Tomson et al.   JOURNAL OF AFFECTIVE DISORDERS

Serotonin 5-HT2 receptor activation prevents allergic asthma in a mouse model

(2015) Felix Nau et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia

(2015) Rajeshwari S. Punekar et al.   CLINICAL CARDIOLOGY

Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

(2015) Patrick M. Moriarty et al.   Journal of Clinical Lipidology

Altered serotonin (5-HT) 1D and 2A receptor expression may contribute to defective insulin and glucagon secretion in human type 2 diabetes

(2015) H. Bennet et al.   PEPTIDES

Statin-induced myopathies

(2014) Michał Tomaszewski et al.   Pharmacological Reports

The Development of Diet-Induced Obesity and Glucose Intolerance in C57Bl/6 Mice on a High-Fat Diet Consists of Distinct Phases

(2014) Lynda M. Williams et al.   PLoS One

The Multifaceted Functions of CXCL10 in Cardiovascular Disease

(2014) Pleunie van den Borne et al.   Biomed Research International

5-Hydroxytryptamine and Its Receptors in Systemic Vascular Walls

(2013) Takuji Machida et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Role of “Western Diet” in Inflammatory Autoimmune Diseases

(2013) Arndt Manzel et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo

(2013) Felix Nau et al.   PLoS One

Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice

(2011) Shaw-Yung Shai et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Statin-induced myopathy: a review and update

(2011) Thura T Abd et al.   Expert Opinion On Drug Safety

An Essential Role for Diet in Exercise-Mediated Protection against Dyslipidemia, Inflammation and Atherosclerosis in ApoE-/- Mice

(2011) Liliana Cesar et al.   PLoS One

Associations of impaired glucose metabolism and dyslipidemia with cardiovascular diseases: what have we learned from Japanese cohort studies for individualized prevention and treatment?

(2011) Yoshihiro Kokubo   EPMA Journal

Treating statin-intolerant patients

(2011) Marcello Arca et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Statins and inflammation: an update

(2010) Petter Quist-Paulsen   CURRENT OPINION IN CARDIOLOGY

Approach to the Patient Who Is Intolerant of Statin Therapy

(2010) Robert H. Eckel   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

A Murine Model of Obesity With Accelerated Atherosclerosis

(2009) Victoria L. King et al.   Obesity

Serotonin Receptors

(2008) David E. Nichols et al.   CHEMICAL REVIEWS

Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor- -Induced Inflammation with Extraordinary Potency

(2008) B. Yu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Lorcaserin (APD356), a Selective 5-HT2CAgonist, Reduces Body Weight in Obese Men and Women

(2008) Steven R. Smith et al.   Obesity